As someone who occasionally relies on this medication to combat insomnia, I understand the importance of affordable and effective treatment options. The pharmaceutical company Sanofi has recently discontinued the production of generic Zolpidem Winthrop, the only authorized generic version of Ambien. This decision has left millions like me with no choice but to resort back to using Ambien, a drug that costs nearly $700 retail.

Insomnia is not a minor issue; it affects over 70 million people in America alone. Lack of sleep can lead to delusion and impaired functioning, making everyday tasks such as working or driving dangerous. It also impacts our ability to care for our children and maintain our overall health.

Sanofi's decision not only impacts those who are diagnosed with insomnia but also those who rely on sleep aids for occasional use. By discontinuing an affordable option, they have effectively put a price tag on a good night's sleep - one that many cannot afford.

We urge Sanofi to reconsider their decision and continue producing generic Zolpidem Winthrop. The cost difference between this generic brand and Ambien is substantial enough that it could mean the difference between restful nights or restless ones for millions across America.

Please join us in urging Sanofi not just for my sake but for all those affected by this change - sign this petition today!